Eur J Heart Fail 2007;9:684 94. 34. Furie KL, Goldstein LB, Albers GW, et al. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial brillation: a science advisory for healthcare professionals from the American Heart Associ- ation/American Stroke Association. Stroke 2012;43:3442 53. 35. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal de nition of myocardial infarction. J Am Coll Cardiol 2012;60:1581 98. 36. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treat- ments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768 77. 37. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incor- porated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;53:e1 90. 38. The Criteria Committee of the New York Heart Association. Nomen- clature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston, Mass: Little & Brown; 1994. 39. Djousse L, Driver JA, Gaziano JM. Relation between modi able lifestyle factors and lifetime risk of heart failure. JAMA 2009;302: 394 400. 40. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics 2013 update: a report from the American Heart Association. Circulation 2013;127:e6 245. 41. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994 2003. Arch Intern Med 2008;168: 418 24. 42. Roger VL, Weston SA, Red eld MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292:344 50. 43. Owan TE, Red eld MM. Epidemiology of diastolic heart failure. 